Tissue engineering aims to restore and replace damaged organs, with FDA approval for limited human applications. The field began in the 1980s and is characterized by the use of scaffolds and stem cells to regenerate tissues, though it currently faces challenges such as high costs and ethical issues. Despite these obstacles, tissue engineering offers potential advantages like reduced surgeries and no need for organ donors.